Tvardi Therapeutics Inc. (TVRD)

TVRD trades at $40.23, 14.9% above the near-term max pain of $35 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($35-$40), signaling increased put positioning or downside protection. Key magnetic zone at 35 where 2 expirations converge.

Max pain for TVRD shows a downward trend from 40 to 35, indicating bearish sentiment or hedging activity. The 13% spread signals divergent expectations across timeframes. Most levels below 40.23 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.